Genomes and Genes


Fei Dong


Affiliation: Massachusetts General Hospital
Country: USA


  1. Hwang D, Sholl L, Rojas Rudilla V, Hall D, Shivdasani P, Garcia E, et al. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung. J Thorac Oncol. 2016;11:496-503 pubmed publisher
    ..1) and expression of gastrointestinal markers. These findings describe recurrent NKX2-1 mutations in invasive mucinous adenocarcinomas of the lung and support NKX2-1 as a lineage-specific tumor suppressor gene in lung carcinogenesis. ..
  2. request reprint
    Dong F, Davineni P, Howitt B, Beck A. A BRCA1/2 Mutational Signature and Survival in Ovarian High-Grade Serous Carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25:1511-1516 pubmed
    ..This study identifies the use of mutational signatures as a biomarker for survival outcome in ovarian high-grade serous carcinoma. Cancer Epidemiol Biomarkers Prev; 25(11); 1511-6. ©2016 AACR. ..
  3. Nowak J, Yurgelun M, Bruce J, Rojas Rudilla V, Hall D, Shivdasani P, et al. Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. J Mol Diagn. 2017;19:84-91 pubmed publisher
    ..These findings provide a framework for a targeted tumor sequencing panel to accurately detect MMR-D and MSI-H in colorectal carcinomas. ..